FDG uptake reflects an immune-enriched subtype of thyroid cancer: Clinical implications of imaging-based molecular characterization.

Suh, Hoon Young; Choi, Hongyoon; Cho, Sun Wook; Paeng, Jin Chul; Cheon, Gi Jeong; Park, Young Joo; Kang, Keon Wook

Suh, Hoon Young; Choi, Hongyoon; Cho, Sun Wook; Paeng, Jin Chul; Cheon, Gi Jeong; Park, Young Joo; Kang, Keon Wook.

Affiliation

Suh HY; Department of Nuclear Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Choi H; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea.
Cho SW; Department of Nuclear Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Paeng JC; Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, Seoul, Republic of Korea.
Cheon GJ; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Park YJ; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kang KW; Department of Nuclear Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

Cancer Med ; 12(16): 17068-17077, 2023 08.

Article de En | MEDLINE | ID: mdl-37466323

Sujet(s)
Mots clés

2-deoxy-2-fluoro-D-glucose; glucose transport proteins; glycolysis; thyroid neoplasms; tumor microenvironment

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la thyroïde / Fluorodésoxyglucose F18 Limites: Humans Langue: En Journal: Cancer Med Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google